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In Staphylococcus aureus, the sigB operon codes for the alternative sigma factor B and its regulators that
enable the bacteria to rapidly respond to environmental stresses via redirection of transcriptional priorities.
However, a full model of B regulation in S. aureus has not yet emerged. Earlier data has suggested thatmazEF,
a toxin-antitoxin (TA) module immediately upstream of the sigB operon, was transcribed with the sigB operon.
Here we demonstrate that the promoter PmazE upstream of mazEF is essential for full 
B activity and that
instead of utilizing autorepression typical of TA systems, sigB downregulates this promoter, providing a
negative-feedback loop for sigB to repress its own transcription. We have also found that the transcriptional
regulator SarA binds and activates PmazE. In addition, PmazE was shown to respond to environmental and
antibiotic stresses in a way that provides an additional layer of control over sigB expression. The antibiotic
response also appears to occur in two other TA systems in S. aureus, indicating a shared mechanism of
regulation.
The ability of the major human pathogen Staphylococcus
aureus to respond to challenging biotic (e.g., the nares of
healthy individuals) (27) and abiotic environments (e.g., cath-
eters, clothing, and doorknobs) (45) has promoted its persis-
tence and transmission within hosts. As a result, S. aureus is
now endemic to many hospitals and has become the leading
cause of postoperative surgical infections (46). Furthermore,
these adaptive responses have contributed to the sharp in-
crease in S. aureus skin and soft tissue infections seen in non-
risk populations in the community (26). The ability of S. aureus
to survive adverse host conditions is mediated by the alterna-
tive sigma factor B, which redirects RNA polymerase to tran-
scribe genes involved in environmental stress responses (22).
Although all B-positive organisms use B to regulate stress
response, pathogenic organisms such as S. aureus and L. mono-
cytogenes appear to have an expanded role for B in virulence
gene expression (5, 47). Therefore, determining how B is
regulated in S. aureus is crucial to understanding not only the
bacteria’s response to stress but also how it impacts virulence.
All B-positive organisms appear to share a similar B reg-
ulatory core, wherein B is bound in an inactive state by its
anti-sigma factor RsbW. Dephosphorylated RsbV, the anti-
anti-sigma factor, disrupts the association of B with RsbW,
hence regulating the amount of free B (24). However, regu-
lation outside this core set of interactions is less well conserved
among gram-positive bacteria. For example, S. aureus lacks
equivalents to the physical stress sensing RsbRST and the
nutritional state sensing RsbPQ of Bacillus subtilis (22). The
only known regulator of the RsbV/RsbW interaction in S.
aureus is RsbU, which promotes the disassociation of B from
RsbW by dephosphorylating RsbV. However, as B is still
partially active in a rsbU mutant (36), additional factors are
likely responsible for regulating this activity.
Immediately upstream of the rsbUVW-sigB operon, which
codes for B and its regulators, are two small genes, mazF
(SA1873) and mazE (SAS0167) (see Fig. 1E), which similar to
their Escherichia coli namesakes (1), encode a toxin-antitoxin
(TA) system (17). TA systems are common among prokaryotes
and typically consist of a labile antitoxin that binds and inac-
tivates a more stable toxin (18). Cellular proteases (e.g., Lon
and ClpP) normally degrade these antitoxins, ensuring toxin
activation if antitoxin production ever becomes interrupted.
Starvation and antibiotic exposure are the most well-described
stimuli of TA systems, leading to hypotheses that TA systems
could be used as either a form of bacterial programmed cell
death or as a way to selectively shut down the bacterium’s
metabolism (1, 18). Other hypotheses have laid out possible
roles of TA systems in stabilizing nearby sections of the chro-
mosome, in phage resistance, or in mediating the emergence of
persister cells (33).
In the present study, we expand the existing model of B
regulation in S. aureus to include the transcriptional contribu-
tion from PmazE. We describe how the PmazE impacts 
B activ-
ity and how its activation by heat and antibiotic stress provides
an additional mechanism for sigB regulation. We also detail
the genetic regulation of this promoter, noting that transcrip-
tional regulator SarA directly activates PmazE and demonstrate
that unlike other TA systems, the mazEF system is not auto-
regulated. Instead, this promoter is negatively regulated by
sigB, which serves to create a feedback loop for repression of
its own transcription. Together, these data allow us to update
S. aureus sigB regulation, as well as to describe the genetic
factors involved in the regulation of this TA system.
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MATERIALS AND METHODS
Bacterial strains, plasmids, primers, and growth conditions. All bacterial
strains and plasmids used in the present study are listed in Table 1. Unless
otherwise noted, cells were grown shaking at 250 rpm at 37°C in Luria-Bertani
(LB) for E. coli or Trypticase soy broth (TSB; Fisher Scientific) or 03GL for S.
aureus strains. Optical densities were recorded by their measurement in a Biotek
FL600 (BioTek Instruments) or by dilution of cultures to the linear range of a
Spectronic 20D (Spectronic). Antibiotics were used at the following concen-
trations: erythromycin at 2.5 g/ml, ampicillin at 50 g/ml, and chloramphenicol
at 10 g/ml. The sequences of oligonucleotides used (IDT Technologies) are
available upon request.
Genetic manipulations. Plasmids were isolated from E. coli using the Qiaprep
Spin Kit (Qiagen), and from S. aureus as described previously (42). Transduction
of the sarA::ermC disruption from ALC1342 to Newman was carried out using
phage 80 as described previously (44).
gfpuvr reporter gene constructs. Transcriptional gfpuvr fusions to various pro-
moters were created by cloning PCR-amplified promoter fragments from strain
Newman into pCR2.1 using the Topo TA cloning kit (Invitrogen). Recombinant
pCR2.1 plasmids were digested with EcoRI and the promoter fragment sub-
cloned into pALC1484, a shuttle plasmid containing a promoterless gfpuvr. Li-
gation products were verified by restriction digestion and sequenced for correct
orientation.
Allelic replacement and complementation in S. aureus. Flanking sequences
1 kb on either side of the gene to be deleted were amplified by PCR from
the Newman chromosome, joined together via complementary overhangs and
reamplified by using a second set of flanking primers in a subsequent PCR.
The resulting 2-kb PCR product was then ligated into pMAD, a tempera-
ture-sensitive shuttle plasmid. Allelic exchange was then performed as de-
scribed previously (2). To create an S. aureus strain with altered A binding
sites at the PmazE, complementary primers containing G/T and A/C transver-
sions at the 10 and 35 promoter boxes upstream of mazE (SAS0167) were
used to perform site-directed mutagenesis with the QuikChange II kit (Agi-
lent) on pALC4772, a derivative of pMAD containing the native mazEF
genes. Transversions at both sites were verified by sequencing, and this
plasmid containing the mutated PmazE, as well as an intact copy of mazEF,
was used in allelic replacement in ALC4072, a mazEF deletion mutant of
Newman. To complement these deletions and mutations, a pMAD construct con-
taining the target gene flanked by 1 kb on either side was used to return the gene
to the chromosome by using allelic replacement. All generated strains were verified
by PCR and chromosomal sequencing.
Gel shift analysis. Electrophoretic mobility shift assays (EMSA) were performed
with purified MazE (17), MazF (17), or SarA (a gift from Gongyi Zhang, National
Jewish Hospital) using promoter fragments end labeled with [-32P]ATP by T4
polynucleotide kinase (NEB) and purified by ProbeQuant G-50 microcolumns (GE)
according to the manufacturer’s instructions. The labeled DNA fragment (1.8 nM;
10,000 cpm) was incubated at room temperature for 20 min with the indicated
amounts of purified protein in 25 l of binding buffer (25 mM Tris-HCl [pH 7.5], 0.1
mM EDTA, 75 mM NaCl, 1 mM dithiothreitol and 5% glycerol) containing 0.5 g
of calf thymus DNA. Samples were then resolved on 6% polyacrylamide gels in 0.5	
Tris-borate-EDTA, dried, and autoradiographed.
Quantitation of sigB phenotypes. Staphyloxanthin production in various
strains was quantitated as described earlier (30). Spontaneous and induced
autolysis assays were performed as described previously (29).
Isolation of RNA and Northern blot hybridization. Overnight cultures of S.
aureus were diluted 1:1,000 in 100 ml of TSB in 250 ml side-arm flasks (flask/
medium ratio of 2.5:1) and grown shaking at 250 rpm at 37°C. The cells were
withdrawn at various time points and centrifuged at 4°C for 10 min, and the
pellets were frozen in liquid nitrogen until all samples from all time points were
collected. The cells were then disrupted with 1 ml of cold TRIzol (Invitrogen)
plus 0.25 ml of 0.1-mm-diameter silica/glass beads (Biospec Products) in a re-
ciprocating shaker at the maximum setting for two 1-min pulses (Biospec Prod-
ucts). RNA purification and subsequent Northern analysis was then performed
as described previously (8).
Quantification of transcript levels by real-time PCR. RNA was isolated as
described above except that purified RNA was resuspended in diethyl pyrocar-
bonate-treated double-distilled water. Real-time PCR was conducted as de-
scribed previously (34), and quantification of the cDNA levels relative to gyrB
was performed according to the instructions of the Maxima SYBR kit (Fermen-
tas) with a LightCycler 1.5 system (Roche). Relative quantification analysis was
done using the LightCycler software version 4.0 (Roche).
Primer extension analysis. Mapping the 5
 end of the mazEF transcript by
primer extension was performed using two primers complementary to the mazEF
coding strand located at either nucleotide position 146 or 74 from the ATG
start codon. Primer extension was carried out by using 30 g of total RNA
isolated from Newman wild type grown to postexponential phase as described
previously (4). The same radiolabeled primer was used for DNA sequencing
reactions to provide the reading frame.
Transcriptional fusion analyses. Overnight cultures of S. aureus strains con-
taining transcriptional fusions of various promoters to gfpuvr were diluted to an
A650 of 0.1 in TSB containing 10 g of chloramphenicol/ml and grown at 37°C
with shaking (250 rpm) (tube/medium ratio of 6:1). Aliquots were then taken at
various time points, whereupon the fluorescence and A650 were measured by
using a FL600 microplate reader. For solid medium assays, 50 l of an overnight
culture was spread on Trypticase soy agar containing 10 g of chlorampheni-
col/ml and incubated at 37°C for 24 h with an antibiotic disk (BD) or an Etest
strip (AB Biodisk). Fluorescence was then recorded by a digital camera using a
485-nm light source and a 518-nm filter. To isolate RNA, the 2-mm region
proximal to the growth-inhibitory ring created by diffused antibiotics were
scraped and resuspended into sterile phosphate-buffered saline. RNA was ex-
tracted immediately from half of these cells as described above, while the re-
maining half were evaluated for fluorescence and A650 in a Biotek FL600 mi-
croplate reader.
TABLE 1. Bacterial strains and plasmids used in this study
Strain or plasmid Genotype and/or characteristics Source orreference
Strains
S. aureus
RN4220 Heavily mutagenized NCTC 8325-4 28
Newman Overexpresses clfA and sae 16
SA1873 Newman mazF::mariner at 6 of
mazF
3
ALC1342 RN6390 sarA::ermC 9
ALC1820 Newman sarA::ermC, transductant
of ALC1342
This study
ALC4072 Newman mazEF This study
ALC4434 Newman sigB This study
ALC4948 Newman PmazE scramble This study
ALC5084 Newman mazEF complement This study
ALC5695 Newman sigB complement This study
ALC5696 Newman sarA complement This study
ALC6476 Newman axe1/txe1 This study
ALC6477 Newman axe2/txe2 This study




pCR2.1 Topo cloning vector Invitrogen
pMAD Allelic replacement vector 2
pALC1484 pSK236 containing promoterless
gfpuvr gene
10
pALC2201 pALC1484 with asp23 promoter
fragment
36
pALC3961 pALC1484 with PmazE fragment This study
pALC6478 pALC1484 with axe1/txe1 promoter
fragment
This study
pALC6479 pALC1484 with axe2/txe2 promoter
fragment
This study
pALC4401 pMAD/sigB This study
pALC4771 pMAD/sigB complement This study
pALC4109 pMAD/mazEF This study
pALC4772 pMAD/mazEF complement This study
pALC5708 pMAD/PmazE scramble This study
pALC5699 pMAD/sarA complement This study
pALC6480 pMAD/axe1/txe1 This study
pALC6481 pMAD/axe2/txe2 This study
2796 DONEGAN AND CHEUNG J. BACTERIOL.
RESULTS
mazEF is transcribed both as part of the sigB operon and as
a smaller transcript. The mazEF genes encode a TA system
(17) located immediately upstream of the rsbUVW-sigB operon
and have been reported to be transcriptionally linked during
heat shock (19, 29, 43). However, the transcriptional profile of
these genes outside of heat shock has not been well character-
ized. Accordingly, we examined their transcription during var-
ious stages of cell growth. Northern blot analyses using a sigB
probe were performed on RNA isolated from Newman wild
type at various points during exponential and stationary growth
(Fig. 1A). sigB-containing transcripts 3.7, 2.7, 1.6, and 1.2 kb in
size were seen in growth phases from early exponential
through early-stationary-phase cultures when grown either in
TSB (Fig. 1B) or 03GL (data not shown). However, during
late-stationary-phase conditions (t  16 h, Fig. 1A), sigB-re-
lated transcription was markedly decreased, most notably the
3.7-kb transcript. To identify whether this 3.7-kb sigB transcript
also contained mazEF, we isolated RNA from a mazEF strain
grown to similar time points in TSB. As seen from comparing
Fig. 1B and C, the 3.7-kb band seen in wild type was replaced
by a 3.2-kb band in the mazEF strain, a size difference that
corresponded to the deletion of mazEF (530 bp). These data
implied that mazEF was transcriptionally linked to the sigB
operon during normal growth conditions and that, as a culture
enters the late stationary phase, the transcription of sigB and
mazEF both become greatly reduced.
In order to fully characterize the transcriptional activity of
this locus, a mazF probe was also hybridized to wild-type New-
man RNA. As expected, the 3.7-kb transcript was present at a
low level throughout growth until it disappeared in late sta-
tionary phase (t  16 h) (Fig. 1B). To confirm that the 3.7-kb
transcript indeed encompassed mazEF, as well as the sigB
operon (rsbUVW-sigB), we created a Newman strain with its
mazEF genes intact but with an inactivated promoter. To iden-
tify the exact site of PmazE, we performed primer extension
studies on mRNA isolated from strain Newman. In agreement
with data from Senn et al. (43), the transcriptional start site
was found to be 46 bp upstream of the translational start site
of mazE (data not shown), and the deduced 10 and 35
FIG. 1. Analysis of mazEF and sigB operon transcription. (A) Samples were withdrawn at various points during growth (indicated as points 1
to 6), and their A650 values were measured by using a Biotek FL600. (B to D) Northern blot analysis of these time points showing sigB transcripts
from Newman wild-type (B) and mazEF (C) strains and of mazF transcripts from Newman wild type (D). The sizes of relevant bands are indicated
on the right, and rRNA sizes are indicated to the left. Ethidium bromide staining of 16S rRNA is shown to demonstrate equivalent RNA loading.
(E) Schematic model of the mazEF and sigB operons in S. aureus. Transcripts and their respective promoters are above the diagram, while
rho-independent transcriptional terminators are indicated below. The G values for the terminators downstream of mazF and sigB are 3.6 and
16.9 kcal/mol, respectively. Locus names and their respective lengths are from the N315 genome annotation. Shown in detail is the promoter PmazE,
with its predicted transcriptional start site (1, underlined), 10 and 35 A binding sites (highlighted in gray), and TG residues indicating an
extended10 region (gray highlight with black border). Arrows a and b mark an inverted repeat of DNA and the SarA consensus binding site (12),
and the homology to the PmazE region is indicated at the bottom.
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promoter boxes were found to be consistent with those of a
A-regulated promoter. We also noted the presence of a 5
-
TG-3
 site at position 15/16 (shaded box in Fig. 1E). This
suggests that PmazE has an extended 10 motif, which provides
additional points of contact for the RNA polymerase holoen-
zyme (7, 23). Based on this information, we created a PmazE
scrambled strain with transversional mutations in these 10
and 35 regions (unboxed shaded regions in Fig. 1E). North-
ern blot analysis of this strain using a sigB probe confirmed the
absence of the 3.7-kb transcript but not of the 2.6- and 1.6-kb
transcripts (data not shown).
To ascertain whether inactivation of PmazE or deletion of the
mazEF genes affected expression of rsbU-related transcripts,
we conducted real-time PCR with rsbU specific primers. Inter-
estingly, rsbU-related transcripts remained unchanged in the
mazEF mutant compared to the wild type, suggesting that the
mazEF genes do not themselves modulate the activity of PA,
the A-dependent promoter immediately upstream of rsbU
(Fig. 1E). In contrast, rsbU-related transcripts were markedly
decreased in the PmazE scramble strain (Fig. 2A), demonstrat-
ing that the 3.7-kb mazEF-rsbUVW-sigB transcript from PmazE
contributes significantly to rsbU-related transcription and that
the PA promoter that initiates the rsbUVW-sigB transcript is
likely to be weak.
Besides the 3.7-kb transcript, several smaller transcripts also
appeared in the mazF Northern blot (Fig. 1D). While most of
these are likely cross-hybridization bands generated from high
amounts of nearby 23S and 16S rRNA, a distinct 700-bp
transcript was observed, a size that corresponds to mazEF (530
bp) (Fig. 1D). These data indicated that mazEF was not only
part of the sigB operon but was also transcribed as a smaller
transcript on its own. Furthermore, this transcript was shown
to be lacking in both the PmazE scramble strain and the
mazEF strain (data not shown). The existence of the 0.7-kb
transcript prompted us to look for some form of transcriptional
termination downstream of mazF. In silico work by de Hoon et
al. (14) has previously predicted a rho-independent terminator
184 bp after the mazF stop codon (Fig. 1E). However, the free
energy for this stem-loop is very low compared to the average
free energy of hairpin structures in S. aureus (G  3.6
versus 16.9 kcal/mol, respectively) (14), thus suggesting that
transcriptional readthrough could occur to yield both the 0.7-
and 3.7-kb mazEF-related transcripts.
PmazE, but not mazEF, is necessary for full 
B activity. An
early observation spurring our interest in mazEF was that the
activity of the sigB-dependent asp23 promoter was greatly re-
duced in a S. aureus Newman strain containing a mariner trans-
poson insertion in mazF (data not shown). When we evaluated
a Newman strain with a clean deletion of the mazEF genes
(ALC4072) in a similar manner, no difference in either asp23
promoter activity was observed between this mutant and its
parent, however, (Fig. 3A). A slight increase in sigB transcrip-
tion was seen in this strain by real-time PCR analysis (Fig. 2B)
but not at a level detectable by Northern analysis (Fig. 1B and
C). As an additional verification that mazEF did not affect B
activity, the sigB-dependent PB was also shown not to be al-
tered in a mazEF strain when examined with a transcriptional
fusion of PB to gfpuvr (data not shown).
We next considered the possibility that PmazE itself may
contribute to B activity since the mazF::mariner insertion
might have also disrupted this upstream promoter. In compar-
ing the asp23 promoter activity of the PmazE scramble to that of
the wild type, we found greatly reduced but not abolished
activity in the promoter scramble strain (Fig. 3A), similar to
the levels seen in the mazF::mariner strain. We also ascertained
the level of sigB transcript in this promoter scramble strain by
real-time PCR and found it to be intermediate between the
wild type and the sigB mutant (Fig. 2B). These data linked
the reduction in overall B activity to the alterations in the10
and 35 promoter boxes of PmazE, thus indicating PmazE con-
tributes to optimal transcriptional activation of sigB.
FIG. 2. Real-time PCR analysis of transcripts in the mazEF-rsbUVW-sigB operon. Relative quantification analyses of cDNAs derived from
RNA of late-logarithmic-phase (A650  1.5) S. aureus cells were made using primer pairs to rsbU (A), sigB (B), or mazF (C) and normalized to
gyrB levels. The data represent mean values for three experiments the standard deviation. *, P 0.0001; **, P 0.0003 (compared to the control
[Student t test]).
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Inactivation of PmazE results in partial sigB deficient phe-
notypes. Since transversional mutations in PmazE resulted in
decreased B activity, we investigated whether this strain ex-
hibited other sigB-deficient phenotypes. Since the S. aureus
pigment staphyloxanthin has been demonstrated to be regu-
lated by sigB (25), we quantitated staphyloxanthin levels for
wild-type, sigB, mazEF, and PmazE scramble strains. As seen
in Fig. 3B, the staphyloxanthin level of a mazEF strain was
unchanged relative to wild type, while it was reduced in a PmazE
scramble strain. As a control, the sigB mutant exhibited a very
low level of staphyloxanthin pigment. Notably, the pigment
level in the promoter scramble strain was not as low as that of
the sigB strain, thus indicating partial B activity, consistent
with the pattern that we have observed with regard to asp23
promoter activity levels.
We also examined autolysis in these strains because (i) Kul-
lik et al. noted an autolysis defect in IKA54, a S. aureus 8325-4
strain with an integrated plasmid disrupting the 1.1-kb region
of alr and mazE (29), and (ii) autolysis is negatively regulated
by arlRS, which in turn is positively controlled by sigB (35).
While rates of spontaneous autolysis were found to be un-
changed in these strains (data not shown), significant differ-
ences were seen when cells were exposed to 0.05% Triton
X-100, an autolysis-inducing condition (Fig. 3C). Both the
FIG. 3. Quantitation of sigB phenotypes. (A) Overnight (16 h) fluorescence levels (518 nm) from strains containing pALC2201, a plasmid with
asp23 promoter fusion to gfpuvr, were recorded and normalized to A650. (B) Methanol-extracted staphyloxanthin levels were determined by A450
and normalized to the cell number (A650). (C) Rates of induced autolysis in 0.05% Triton X-100 static at 30°C were measured by comparing the
A650 of each strain at time points as a percentage of their original A650. Symbols: , wild type; E, mazEF; ‚, PmazE scramble; ƒ, sigB; ,
mazF::mariner. The data represent mean values for three experiments  the standard deviation. *, P  0.005; **, P  0.05 (compared to the
control [Student t test]).
FIG. 4. TA promoter levels in S. aureus wild-type and TA deletion strains. Strains transformed with plasmids containing transcriptional fusions
to gfpuv under the control of PmazE (pALC3961) (A), axe1/txe1 promoter (pALC6478) (B) or axe2/txe2 promoter (pALC6479) (C) were grown
overnight (16 h), and their fluorescence levels at 518 nm were measured and normalized to the A650. The data represent mean values for three
experiments  the standard deviation. *, P  0.05 (compared to the control [Student t test]).
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sigB mutant and the mazF::mariner mutant (tested for its
similarities to IKA54) showed significantly enhanced autolytic
activities compared to the wild-type or mazEF strains, but the
PmazE scramble strain had an autolysis phenotype intermediate
between the wild-type and the sigB strains. These findings
supported our hypothesis of reduced B activity in the PmazE
scramble strain and indicated that transcription from PmazE is
necessary for full expression of sigB.
PmazE in S. aureus is not autoregulated. A common mecha-
nism of regulation among TA systems is that the antitoxin,
either with or without its cognate toxin, binds at specific pal-
indromic sequences and hence represses its own promoter (20,
48). However, no such motifs were found in the S. aureus PmazE
promoter using in silico analyses; curiously, a region of in-
verted repeats at 19 to 45 bp upstream of the transcrip-
tional start site was found (arrows in Fig. 1E). To address
FIG. 5. Effect of sarA and sigB on the promoter PmazE. (A) Fluorescence (518 nm) levels were normalized to the A650 of Newman wild-type,
sarA::ermC and sigB strains carrying a transcriptional fusion of PmazE to gfpuvr (pALC3961) during growth through 24 h. (B and C) Fluorescence
at 518 nm from wild-type, sigB, sarA::ermC, and PmazE scramble strains and their complementation strains. The data are presented as mean values
for three experiments  the standard deviation. *, P  0.0001 (compared to the control [Student t test]).
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whether MazE and/or MazF interacted with this or another
cryptic binding site, we performed electrophoretic mobility
shift assays (EMSAs) with a PmazE fragment spanning 12 to
150 bp upstream of the mazE start codon and purified MazE
and/or MazF (17) at concentrations ranging from 40 to 960 nM
(48). However, these studies failed to disclose an interaction
between MazE and/or MazF and the promoter fragment (data
not shown). Additional EMSAs using the promoters upstream
of rsbU and rsbV and MazE and/or MazF also did not show any
binding activity (data not shown). To confirm this lack of as-
sociation for PmazE, we examined PmazE activity in both New-
man wild-type and mazEF mutant strains containing a mazEF
transcriptional fusion to gfpuvr in trans (pALC3961). As com-
parisons, we also constructed strains with deletions of two
other TA systems, axe1/txe1 and axe2/txe2 (SA2196-5 and
SA2246-5, respectively) (21, 38), and transformed these strains
with plasmids containing TA promoters driving gfpuvr tran-
scriptional fusions. While both axe1/txe1 and axe2/txe2 showed
specific repression of their own promoters (Fig. 4B and C),
similar autorepression did not exist for the mazEF system (Fig.
4A). Collectively, these data suggest that mazEF is unique
among S. aureus TA systems in that it does not repress its own
promoter.
PmazE is negatively regulated by sigB. Since mazEF lacked a
form of regulation conserved among all other TA systems (17),
we screened a variety of S. aureus mutant strains containing
pALC3961, a plasmid containing PmazE driving gfpuvr, for pos-
sible regulators of PmazE. Interestingly, we observed increased
fluorescence in a sigB deletion mutant compared to the wild
type (Fig. 5A), up to a threefold increase after overnight
growth (Fig. 5C). This increase returned to wild-type levels
upon complementation (Fig. 5B). This repression on PmazE by
sigB was also corroborated by other studies, including (i) real-
time PCR data showing both increased mazF and rsbU tran-
scripts in a sigB mutant strain compared to the Newman wild
type (Fig. 2A and C); (ii) increased mazEF transcription rates
in strains with mutations in positive regulators of B activity
(e.g., rsbU and rsbV mutants) (data not shown); (iii) the rsbU-
deficient strain RN6390 had increased mazEF transcription
compared to the rsbU-restored strain SH1000 (data not
shown); and (iv) the PmazE scramble mutant, which exhibited
decreased B activity, showed enhanced in trans mazEF tran-
scriptional activity from pALC3961 compared to the wild type
(Fig. 5B). Taken together, these data indicate that sigB re-
presses mazEF transcription.
PmazE is positively and directly regulated by sarA. Our
screen for S. aureus strains with mutations affecting PmazE
activity also showed that a sarA::ermC mutant had decreased
PmazE activity compared to wild type during growth (Fig. 5A),
although this difference was narrowed somewhat in overnight
growth (Fig. 5C). The decrease in PmazE activity in the sarA
mutant was restored to the wild-type level upon complemen-
tation (Fig. 5C). As sarA is a global regulator in S. aureus at the
center of a complex network of gene regulation (11, 15), it was
necessary to ascertain whether SarA interacted directly with
PmazE. Interestingly, a region of high homology to the consen-
sus SarA binding site (12) containing an imperfect 8-bp palin-
dromic sequence (AAAATATA) flanked by a center stretch of
nine nucleotides was identified starting at 21 bp upstream of
the mazE transcription start site (Fig. 1E). Using the same
PmazE fragment as in the EMSA experiments with MazE and
MazF, we observed binding of purified SarA to this fragment,
which could be competitively displaced by the addition of a
100-fold excess of unlabeled fragment, demonstrating specific-
ity of binding (Fig. 6). Densitometric analysis of this EMSA
revealed that the affinity (Kd) of SarA for PmazE was 190 nM,
a value in accordance with previous reports (39).
PmazE is activated in response to various stress conditions.
TA systems have been shown to be either up- or downregu-
lated after exposure to heat or antibiotics (6, 13, 41). Previous
studies have shown that a 48°C heat shock upregulates sigB
transcription in S. aureus (43). Since mazEF is a TA system
cotranscribed with sigB, we felt it necessary to better define the
activity of PmazE during various stresses. We first verified the
effect of heat on mazEF transcription. As seen in Fig. 7, no
elevation in either the 2.6-kb rsbUVW-sigB transcript from PA
or the 1.6-kb rsbVW-sigB from PB was seen in Newman wild
FIG. 6. SarA EMSA using a PmazE fragment. A [-
32P]ATP-labeled
PmazE fragment (1.8 nM; positions 12 to 150 bp from the mazE
start codon) was incubated with increasing concentrations of SarA
protein (nM) and resolved by native polyacrylamide gel electrophore-
sis. Specific competition for PmazE by SarA was performed by the
addition of 100-fold excess unlabeled PmazE.
FIG. 7. Northern blot analysis of sigB transcripts from Newman
wild type during growth at 37°C or after a shift to 45°C. The sizes of the
relevant bands are indicated on the right, and rRNA sizes are indicated
to the left. Ethidium bromide staining of 16S rRNA is shown to
demonstrate equivalent RNA loading.
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type grown at 45°C, while transcription of the 3.7-kb transcript
from PmazE was increased under this condition (Fig. 7). A
similar increase in transcription from PmazE after heat shock
was seen using a mazF probe (data not shown).
To clarify the effects of antibiotics on mazEF transcription,
we first exposed Newman cells containing pALC3961 to an
antibiotic gradient generated from an Etest strip. We observed
that cells grown in the zone from one-quarter to the full MICs
of tetracycline (125 to 500 ng/ml) became more fluorescent
than untreated cells (Fig. 8A), indicating increased mazEF
transcription in these regions. Other antibiotics (e.g., penicillin
and linezolid) showed increases in similar ranges, while van-
comycin produced no significant changes in fluorescence in
these regions (data not shown). To quantitate these effects,
RNA was purified from cells at this periphery and analyzed by
real-time PCR. We observed that mazEF transcription was
increased after exposure to tetracycline and erythromycin, but
not vancomycin (Fig. 8B), a finding similar to what we ob-
served in our fluorescence studies. Northern blot studies with
a mazF probe also confirmed these findings for the 3.7-kb band
(Fig. 9, top panel) and the 0.7-kb band (data not shown).
Interestingly, a similar pattern was also noted for asp23 tran-
scription (Fig. 8C), again suggesting a role for PmazE in con-
trolling overall B activity. Based on these results, we con-
cluded that not all antibiotics affect PmazE, but those that do,
do so strongly, and that this activity can be triggered from a full
MIC down to one-quarter of the MIC. Furthermore, these
data indicated that mazEF transcription can remain elevated
for over 24 h in cells grown on solid agar in the presence of
subinhibitory concentrations of antibiotics.
Antibiotics stimulate transcription of other TA systems in S.
aureus. The induction of mazEF transcription upon exposure
to some antibiotics made us curious as to whether axe1/txe1 and
axe2/txe2 in S. aureus were similarly affected. Accordingly, we
extracted RNA from S. aureus Newman cells exposed to sub-
inhibitory concentrations of tetracycline (78 ng/ml), erythro-
mycin (312 ng/ml), and vancomycin (1 g/ml) and performed
Northern blot analysis using probes to txe1 and txe2. Under
FIG. 8. (A) Antibiotic-induced fluorescence from Newman wild type containing a mazEF transcriptional fusion to gfpuvr (pALC3961) grown on
solid media. After 24 h of exposure to a tetracycline gradient created by an Etest strip, the fluorescence was recorded by using 518-nm filtered
optics. (B and C) Relative quantification of mazF (B) and asp23 (C) transcripts by real-time PCR of cDNA from Newman wild-type cells 1 to 2
mm proximal to the zone of clearing (i.e., the MIC) of tetracycline, erythromycin, or vancomycin disks. Newman wild type grown without exposure
to antibiotics was used as a no-drug control. The data are presented as mean values for three experiments  the standard deviation. *, P  0.0001;
**, P  0.0005 (compared to the control [Student t test]).
FIG. 9. Northern blot analyses of mazEF, axe1/txe1, and axe2/txe2
mutants were performed on RNA purified from Newman cells exposed
to erythromycin (312 ng/ml), tetracycline (78 ng/ml), or vancomycin (1
g/ml). The sizes of the relevant bands are indicated on the right, and
the staining patterns of 16S rRNA with ethidium bromide for each gel
are shown below.
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noninducing conditions, both axe1/txe1 and axe2/txe2 were
transcribed as 0.6-kb mRNAs, corresponding to the genes in
each system (Fig. 9). In addition, axe2/txe2 was also part of an
1.8-kb transcript, likely encompassing the neighboring SA2244,
a 1,077-bp gene that encodes a putative endo-1,4--glucanase.
After antibiotic challenge, we also observed a transcriptional
pattern similar to that of mazEF (Fig. 9). More specifically,
both axe1/txe1 and axe2/txe2 transcripts were upregulated after
exposure to erythromycin and tetracycline, but not with van-
comycin. Furthermore, transcription of all of these systems
reached their maximum within 30 to 45 min of exposure to
either erythromycin or tetracycline. Together, these results
indicate that all known TA systems in S. aureus are rapidly
activated upon exposure to subinhibitory concentrations of
selective antibiotics and likely remain so for the duration of the
exposure.
DISCUSSION
In this study, we demonstrated that the A-dependent pro-
moter PmazE contributes to 
B activity by producing a 3.7-kb
mazEF-rsbUVW-sigB mRNA. We observed this promoter to be
inducible by heat shock and by exposure to subinhibitory con-
centrations of certain antibiotics, which boost sigB transcrip-
tion and B activity under these conditions. In addition, a small
0.7-kb mazEF transcript was also observed, likely due to tran-
scriptional termination from a weak rho-independent termina-
tor between mazF and rsbU (14). Interestingly, other species
with a similar sigB operon structure (i.e., B. subtilis, Listeria
spp., and other Staphylococcus spp.) all had much stronger
transcriptional terminators in this location (14), which presum-
ably prevent readthrough by RNA polymerase. This finding
suggests that cotranscription of mazEF with rsbUVW-sigB, and
hence PmazE’s influence on 
B activity, may be limited solely to
S. aureus. Furthermore, as sigB in S. aureus also controls se-
lective aspects of virulence gene expression in addition to
stress response (5), we speculate that the linking of this pro-
moter to the sigB operon in S. aureus may have enhanced
control of this larger regulon.
In the course of these investigations, we were surprised to
find that PmazE was not regulated by its own gene products, in
contrast to all other TA systems examined thus far (18). In-
stead, it appeared to be negatively regulated by sigB, the last
gene in the 3.7-kb mazEF-rsbUVW-sigB transcript. In addition
to sigB repressing mazEF, this may also function as a feedback
loop to return elevated sigB transcription (e.g., after activation
FIG. 10. Proposed model for mazEF regulation in S. aureus. Transcription initiated from PmazE combined with a weak rho-independent
terminator downstream of mazF creates both the 0.7-kb mazEF transcript and a 3.7-kb mazEF-rsbUVW-sigB transcript. This latter transcript is
required for full B activity and contributes significantly to rsbU-related transcripts, since the activity of the PA promoter is weak. Transcription
from PmazE is stimulated by environmental and antibiotic stress, which may be mediated by the direct binding of SarA at the 35 site of the
promoter. Transcription of the 0.7- and 3.7-kb mRNAs is also negatively regulated by sigB, likely through an intermediary. It is possible that this
establishes a negative-feedback loop wherein sigB represses PmazE. The mazEF translational products ultimately produce a TA system in which the
antitoxin MazE binds and inactivates MazF in a higher-order stoichiometry. After proteolytic degradation of MazE by ATP-dependent proteases,
MazF of S. aureus degrades mRNA at the VUUV
 sequence in susceptible mRNA (17).
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of the feed-forward B-dependent PB promoter) to basal lev-
els. However, direct repression of PmazE by sigB is unlikely
since PmazE is a 
A-dependent promoter. One possible mech-
anism for this repression could be via a sigB-regulated repres-
sor. Two such transcriptional repressors in S. aureus, yabJ and
spoVG (5), were examined for such a role, but no differences in
mazEF transcription were observed in either the single or
double deletion mutant strains of these genes (data not
shown). Another possible mechanism might involve sigma fac-
tor competition (32), where the absence of B in a sigB strain
could permit A increased access to RNA polymerase, thus
increasing transcription from A-dependent promoters. Such
competition is seen in B. subtilis after exposure to environmen-
tal stress (40), and we are currently examining S. aureus for
similar regulation.
PmazE was also shown to be positively and directly regulated
by SarA, a winged-helix transcriptional regulator of virulence
gene expression in S. aureus (11, 15). Based on previous pro-
moter binding studies (12, 31), SarA likely binds to an inverted
repeat that overlaps the 35 promoter region of PmazE. While
occlusion of this 35 box by SarA might be initially thought to
reduce A’s ability to initiate transcription at this promoter,
the presence of a 5
-TG-3
 extended 10 motif at position
15/16 from the mazEF transcription start site (23) suggests
this may not be the case. Such a motif has been shown to be
sufficient in compensating for the absence of a 35 region box
of a A promoter (7), and this leniency in promoter require-
ment may enable SarA to act on RNA polymerase as a tran-
scriptional activator. Furthermore, SarA was shown not to bind
to either the PA or PB promoters in the sigB operon (data not
shown), making PmazE the only region where sarA regulation
could affect sigB transcription.
To date, TA transcriptional regulation has been thought to
be mediated solely via autorepression. However, our findings
that sarA and sigB regulate the mazEF system in S. aureus
indicate that diverse regulatory mechanisms may yet exist for
TA systems of other species. Such pathways may finally explain
how TA promoters can be either activated (6, 13) or repressed
(1, 41) following environmental, nutritional, or antibiotic chal-
lenges. Our data here show a similar regulatory flexibility, since
mazEF levels were likely to be lower in the nutritionally de-
pleted conditions of late stationary cultures (t 16 h) but were
increased after heat shock or exposure to antibiotics such as
tetracycline and erythromycin. Interestingly, this induction was
maintained for over 24 h, indicating that these cells remained
transcriptionally active even while producing large amounts of
TA transcripts. A further point of interest was that certain
antibiotics, such as vancomycin, failed to induce TA expres-
sion, indicating that there may be yet further criteria for TA
activation.
In summary, the A-dependent PmazE promoter was revealed
to be essential for full B activity due to its transcriptional linkage
with the downstream sigB operon via readthrough of a weak
downstream rho-independent terminator (Fig. 10). PmazE
drives the 3.7-kb transcript, contributing significantly to the
transcription of rsbU and sigB since the promoter upstream of
rsbU is relatively weak. PmazE was also found to be positively
regulated by SarA, which likely binds at a site overlapping the
35 box. In contrast to all other TA systems examined, auto-
regulation of PmazE was not found to occur, although transcrip-
tional repression by sigB downstream may perform a similar
role. Furthermore, since this promoter was strongly active in
the presence of certain antibiotics or heat shock, but inactive
during late stationary phase, divergent roles for TA systems
may exist during various stress responses.
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